FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21705511000001101: Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71866801000001118 Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71866901000001112 Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has VMP Saxagliptin 2.5mg / Metformin 1g tablets true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient Saxagliptin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Komboglyze 2.5mg/1000mg tablets (DE Pharmaceuticals) 56 tablet Is a True Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Is a True Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Is a True Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start